Skip to content

BioLife Solutions BLFS Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

Revenue-$3.4MMiss by $25.2M
EPS-$0.01Beat by $0.05
Revenue estimate$21.8M
EPS estimate-$0.06

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$27.8M
EPS estimate-$0.01

Financials

Q4 2024

Income statement

See full
Revenue$15.1M
Gross profit$12.5M+21.2%

Balance sheet

See full
Cash & equivalents$95.4M+169%
Total debt$30.2M-27.1%
Total equity$348.9M+3.3%
Total assets$399.5M-3.2%

Cash flow

See full
Operating cash flow$1.6M
CapEx$3.1M+219%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.2B+64.5%
Enterprise value$1.14B+54.3%
P/S16.1×

Profitability

See full
Gross margin67.1%

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio4.5×+1.7×

Versus estimates

Ask the moment BioLife Solutions reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioLife Solutions report Q4 2024 earnings?
BioLife Solutions (BLFS) reported Q4 2024 earnings on March 3, 2025 before market open.
What were BioLife Solutions's Q4 2024 revenue and EPS?
BioLife Solutions reported revenue of -$3.4M and eps of $-0.01 for Q4 2024.
Did BioLife Solutions beat estimates in Q4 2024?
Revenue missed the consensus estimate of $21.8M by $25.2M. EPS beat the consensus estimate of $-0.06 by $0.05.
Where can I find BioLife Solutions's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001628280-25-009511) directly on SEC EDGAR. The filing index links above go to sec.gov.